While passive delivery of drugs to metastatic tumors via the enhanced permeability and retention (EPR) effect has clear clinical significance, the selectivity for tumor versus normal tissue is unsatisfactory, particularly for gene therapies. Enabling image-guided drug delivery (IGDD) would be a valuable strategy to decrease off target effects. Here, we intend to leverage image-guided radiation (IGRT) as a means to target non-viral gene therapy vectors to tumors. Significantly, image-guided radiotherapy already has an established role in treating prostate cancer patients who have developed distant metastatic disease. Here, magnetic resonance (MR) and/or computed tomography (CT) imaging is used to allow precise aiming of radiation to the metastasis, allowing delivery of ablative doses to the tumor while inducing minimal damage to surrounding normal tissue. Importantly, the radiation doses used in IGRT not only kill cancer cells but also alter the tumor microenvironment, leading to increased permeability of tumor blood vessels. We have modeled IGRT of metastatic prostate cancer in mice using MR tumor imaging, image fusion with the on-board CT in the X-RAD 225Cx image-guided small animal radiation device, and treatment planning to deliver precision irradiation to the tumor. Our studies reveal increased vascular permeability in the irradiated tumors, and demonstrate both rapid accumulation and long-term retention of macromolecular imaging agents, an effect that we have named image-guided radiation-induced permeability (IGRIP). We have leveraged IGRIP to enable a novel approach to image-guided drug delivery by targeting nanoparticles to tumors. Here, we will further study and optimize IGRIP as a tool for IGDD and apply this approach to enable tumor-targeted delivery of gene therapy. We will develop a new class of non-viral vector nanoparticle nucleic acid carriers that remain stable in circulation and are delivered efficiently by IGRIP. As a model for translation, we will evaluate IGRIP for image-guided delivery of gene-directed enzyme-prodrug therapy and evaluate this as a strategy to potentiate the effects of radiation. Then, toward translation of personalized image-guided gene therapy, we will evaluate IGRIP as a tool to deliver RNAi for knock-downs and CRISPR nuclease for knock outs targeting oncogenes and DNA repair factors. We hope to enable a new approach wherein radiation is used to drive gene therapy into metastases as a route to improving treatment outcomes by achieving durable local and systemic control.

Public Health Relevance

We now have technology to determine cancer causing mutations in each patient's tumor at diagnosis. However, a means to take full advantage of this information remains lacking as progress on delivering gene therapy to tumors has languished. We propose to use radiotherapy as a tool to target gene therapy to tumors, thereby overcoming current barriers and enabling personalized cancer therapy for many more patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA199663-01
Application #
8972679
Study Section
Special Emphasis Panel (ZRG1-SBIB-Z (58))
Program Officer
Tandon, Pushpa
Project Start
2015-07-16
Project End
2020-06-30
Budget Start
2015-07-16
Budget End
2016-06-30
Support Year
1
Fiscal Year
2015
Total Cost
$512,434
Indirect Cost
$138,253
Name
University of Chicago
Department
Genetics
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Appelbe, Oliver K; Kim, Bieong-Kil; Rymut, Nick et al. (2018) Radiation-enhanced delivery of plasmid DNA to tumors utilizing a novel PEI polyplex. Cancer Gene Ther 25:196-206
Ranoa, Diana Rose E; Widau, Ryan C; Mallon, Stephen et al. (2018) STING promotes homeostasis via regulation of cell proliferation and chromosomal stability. Cancer Res :
Lee, Steve Seung-Young; Bindokas, Vytautas P; Lingen, Mark W et al. (2018) Nondestructive, multiplex three-dimensional mapping of immune infiltrates in core needle biopsy. Lab Invest :
Appelbe, Oliver K; Moynihan, Kelly D; Flor, Amy et al. (2017) Radiation-enhanced delivery of systemically administered amphiphilic-CpG oligodeoxynucleotide. J Control Release 266:248-255
Kwak, Gijung; Kim, Dongkyu; Nam, Gi-Hoon et al. (2017) Programmed Cell Death Protein Ligand-1 Silencing with Polyethylenimine-Dermatan Sulfate Complex for Dual Inhibition of Melanoma Growth. ACS Nano 11:10135-10146
Kim, Bieong-Kil; Kim, Dongkyu; Kwak, Gijung et al. (2017) Polyethylenimine-dermatan sulfate complex, a bioactive biomaterial with unique toxicity to CD146-positive cancer cells. ACS Biomater Sci Eng 3:990-999
Lee, Steve Seung-Young; Bindokas, Vytautas P; Kron, Stephen J (2017) Multiplex three-dimensional optical mapping of tumor immune microenvironment. Sci Rep 7:17031
Park, Jinho; Park, Joonyoung; Pei, Yihua et al. (2016) Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines. Adv Drug Deliv Rev 104:93-109
Appelbe, Oliver K; Zhang, Qingbei; Pelizzari, Charles A et al. (2016) Image-Guided Radiotherapy Targets Macromolecules through Altering the Tumor Microenvironment. Mol Pharm 13:3457-3467